Literature DB >> 5099107

Binding of covalent proteins to polysaccharides by cyanogen bromide and organic cyanates. I. Preparation of soluble glycine-, insulin- and ampicillin-dextran.

L Kågedal, S Akerström.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5099107     DOI: 10.3891/acta.chem.scand.25-1855

Source DB:  PubMed          Journal:  Acta Chem Scand        ISSN: 0001-5393


× No keyword cloud information.
  7 in total

1.  Enhanced plasma persistence of therapeutic enzymes by coupling to soluble dextran.

Authors:  R F Sherwood; J K Baird; T Atkinson; C N Wiblin; D A Rutter; D C Ellwood
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

2.  Production of an antibody-like factor in the sea star Asterias rubens: involvement of at least three cellular populations.

Authors:  M Leclerc; C Brillouet; G Luquet; R A Binaghi
Journal:  Immunology       Date:  1986-03       Impact factor: 7.397

3.  Macromolecular beta-adrenergic antagonists discriminating between receptor and antibody.

Authors:  J Pitha; J Zjawiony; R J Lefkowitz; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

4.  Free radicals and inflammation: superoxide-dependent activation of a neutrophil chemotactic factor in plasma.

Authors:  W F Petrone; D K English; K Wong; J M McCord
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

Review 5.  Polymer conjugates. Pharmacokinetic considerations for design and development.

Authors:  R Duncan; F Spreafico
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

6.  [Evidence of the haptenic nature of peptidomannans from two yeasts: Saccharomyces oviformis and Candida mycoderma].

Authors:  C Charpentier; R Fontanges
Journal:  Mycopathologia       Date:  1977-10-28       Impact factor: 2.574

7.  Affinity purification of bovine antibodies to Brucella abortus Lipopolysaccharide.

Authors:  J M Stiller; K H Nielsen
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.